MassMutual Private Wealth & Trust FSB Sells 68,082 Shares of Danaher Corporation $DHR

MassMutual Private Wealth & Trust FSB lessened its position in Danaher Corporation (NYSE:DHR) by 58.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 49,344 shares of the conglomerate’s stock after selling 68,082 shares during the quarter. MassMutual Private Wealth & Trust FSB’s holdings in Danaher were worth $9,783,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also added to or reduced their stakes in DHR. Mccarter Private Wealth Services LLC boosted its holdings in shares of Danaher by 27.2% in the 3rd quarter. Mccarter Private Wealth Services LLC now owns 2,795 shares of the conglomerate’s stock worth $554,000 after purchasing an additional 598 shares in the last quarter. Kathmere Capital Management LLC raised its holdings in shares of Danaher by 23.7% during the 3rd quarter. Kathmere Capital Management LLC now owns 1,573 shares of the conglomerate’s stock valued at $312,000 after buying an additional 301 shares in the last quarter. Gladstone Institutional Advisory LLC lifted its position in Danaher by 6.9% in the 3rd quarter. Gladstone Institutional Advisory LLC now owns 7,451 shares of the conglomerate’s stock worth $1,477,000 after buying an additional 483 shares during the last quarter. Gries Financial LLC boosted its stake in Danaher by 20.0% in the third quarter. Gries Financial LLC now owns 1,694 shares of the conglomerate’s stock worth $336,000 after buying an additional 282 shares in the last quarter. Finally, Autumn Glory Partners LLC grew its position in Danaher by 28.2% during the third quarter. Autumn Glory Partners LLC now owns 1,365 shares of the conglomerate’s stock valued at $271,000 after acquiring an additional 300 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Insider Buying and Selling

In related news, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the sale, the senior vice president owned 2,625 shares in the company, valued at $552,352.50. The trade was a 66.34% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, Director Teri List sold 3,298 shares of the company’s stock in a transaction on Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the completion of the transaction, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 30,248 shares of company stock valued at $6,609,663 over the last quarter. 11.20% of the stock is owned by company insiders.

Danaher Stock Performance

Shares of NYSE:DHR opened at $236.60 on Wednesday. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33. The company has a 50-day moving average price of $224.48 and a 200-day moving average price of $209.87. The company has a market cap of $167.12 billion, a price-to-earnings ratio of 48.78, a price-to-earnings-growth ratio of 4.19 and a beta of 0.89. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $258.23.

Danaher (NYSE:DHR) last posted its earnings results on Monday, October 20th. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.72 by $0.17. The company had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. Danaher had a return on equity of 10.92% and a net margin of 14.44%.Danaher’s quarterly revenue was up 4.4% on a year-over-year basis. During the same period last year, the firm earned $1.71 earnings per share. As a group, equities analysts anticipate that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Investors of record on Friday, December 26th will be issued a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.5%. The ex-dividend date is Friday, December 26th. Danaher’s dividend payout ratio is currently 26.39%.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on the stock. Rothschild Redb lowered shares of Danaher from a “strong-buy” rating to a “hold” rating in a report on Wednesday, October 8th. KeyCorp reissued an “overweight” rating on shares of Danaher in a research note on Thursday, December 18th. TD Cowen upped their price target on shares of Danaher from $250.00 to $260.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Rothschild & Co Redburn reiterated a “neutral” rating and issued a $220.00 price objective (down previously from $245.00) on shares of Danaher in a report on Wednesday, October 8th. Finally, Robert W. Baird set a $247.00 target price on Danaher in a report on Wednesday, October 22nd. Twenty-one equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $249.50.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.